# BGMSP (Bio Green Med Solution, Inc.) - SEC EDGAR Financial Statements

> Bio Green Med Solution, Inc. reported $0 in revenue and a net loss of $1.66M for the fiscal year ended December 31, 2025 (down 100.0% year over year).

- Canonical: https://convexityos.com/fundamentals/BGMSP
- Markdown: https://convexityos.com/fundamentals/BGMSP.md
- SEC CIK: 0001130166
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:09 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001130166&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | $0 | -100.0% YoY |
| Operating Income | FY 2025 | -$3.16M | Operating profit |
| Net Income | FY 2025 | -$1.66M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.25 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $3.45M | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $0 | $43K | $420K | $0 | $0 | $0 | -- | $150K | $0 | $843K |
| Research & Development | $848K | $6.66M | $19.16M | $20.27M | $15.48M | $4.76M | $4.66M | $4.33M | $4.24M | $9.48M |
| Selling, General & Admin | -- | $5.39M | $6.72M | $7.38M | $7.46M | $5.88M | $5.02M | $5.37M | $5.25M | $5.52M |
| Total Operating Expenses | $9.17M | $12.05M | $25.87M | $27.66M | -- | -- | -- | $9.70M | $9.49M | -- |
| **Operating Income** | -$8.43M | -$12.00M | -$25.45M | -$27.66M | -$22.94M | -$10.64M | -$9.68M | -$9.55M | -$9.49M | -$14.15M |
| **EBITDA** | -$8.42M | -$12.00M | -$25.42M | -$27.62M | -$22.89M | -$10.62M | -$9.66M | -$9.52M | $22.51M | -$14.05M |
| Interest Income | -- | $12K | $266K | $210K | $16K | $42K | $224K | $331K | $118K | $37K |
| Income Before Tax | -$2.99M | -$11.99M | -$25.55M | -$25.91M | -$22.73M | -$9.68M | -$9.13M | -$8.62M | -$8.46M | -$13.77M |
| Income Tax Expense | $7.0K | -$782K | -$3.00M | -$4.72M | -$3.85M | -$1.24M | -$1.30M | -$1.34M | -$993K | -$1.98M |
| **Net Income** | -$3.00M | -$11.21M | -$22.55M | -$21.20M | -$18.89M | -$8.45M | -$7.83M | -$7.29M | -$7.47M | -$11.79M |
| Basic EPS | -$6.45 | -$502.46 | -$6,369.05 | -$6,785.71 | -$7,642.86 | -$12,214.29 | -$35,142.86 | -$44,285.71 | -$139,285.71 | -$250,000.00 |
| **Diluted EPS** | -$6.45 | -$502.46 | -$6,369.05 | -$6,485.71 | -$7,642.86 | -$12,214.29 | -$35,142.86 | -$44,285.71 | -$139,285.71 | -$250,000.00 |
| Basic Shares Outstanding | 2.2M | 22.3K | 3.6K | 3.2K | 2.5K | 1.0K | 229 | 169 | 107 | 48 |
| Diluted Shares Outstanding | 2.2M | 22.3K | 3.6K | 3.2K | 2.5K | 1.0K | 229 | 169 | 107 | 48 |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $454K | $357K | $743K | -- | $81K | -- | -- | $0 |
| Research & Development | -- | -- | -- | -$47K | $5.0K | $68K | $822K | $880K |
| Selling, General & Admin | -- | -- | -- | -- | -- | -- | -- | $948K |
| Total Operating Expenses | $974K | $754K | $1.02M | $2.64M | $1.07M | $1.25M | $4.21M | $1.83M |
| **Operating Income** | -$520K | -$418K | -$246K | -$1.98M | -$987K | -$1.25M | -$4.21M | -$1.83M |
| **EBITDA** | -$520K | -$418K | -$245K | -- | -- | -- | -- | -$1.83M |
| Income Before Tax | -$446K | -$396K | -$167K | $3.45M | -$983K | -$1.25M | -$4.21M | -$1.86M |
| Income Tax Expense | $3.0K | $9.0K | $30K | -- | -- | $2.0K | -- | $1.19M |
| **Net Income** | -$449K | -$405K | -$197K | -$611K | -$988K | -$1.32M | -$81K | -$3.05M |
| Basic EPS | -$0.07 | -- | -- | -- | -$1.31 | -$233.33 | $0.00 | -- |
| **Diluted EPS** | -$0.07 | -- | -- | -- | -$1.31 | -$233.33 | $0.00 | -- |
| Basic Shares Outstanding | 6.6M | 5.6M | 5.5M | -- | 1.9M | 1.4M | 365.2K | -- |
| Diluted Shares Outstanding | 6.6M | 5.6M | 5.5M | -- | 1.9M | 1.4M | 365.2K | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $3.50M | $3.14M | $3.38M | $18.34M | $36.56M | $33.41M | $11.88M | $17.50M | $23.91M | $16.52M |
| Short-Term Investments | -- | -- | -- | $4.55M | $4.48M | $5.33M | $11.14M | $16.69M | $22.81M | $11.19M |
| **Cash & Short-Term Investments** | $3.50M | $3.14M | $3.38M | $22.89M | $41.04M | $38.73M | $23.03M | $34.19M | $46.72M | $27.71M |
| Accounts Receivable, Net | $1.26M | -- | -- | -- | -- | -- | -- | -- | -- | $10K |
| Inventory | $1.38M | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Other Current Assets | -- | $317K | $341K | $426K | $79K | $66K | $103K | $236K | $106K | $41K |
| **Total Current Assets** | $6.26M | $3.67M | $7.44M | $24.41M | $40.94M | $35.47M | $14.02M | $19.79M | $25.97M | $19.62M |
| Property, Plant & Equipment, Net | $137K | $3.0K | $9.0K | $32K | $64K | $106K | $27K | $36K | $29K | $45K |
| Goodwill | $1.57M | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| **Total Non-Current Assets** | $1.93M | $420K | $1.36M | $3.64M | $1.65M | $1.33M | $1.29M | $36K | $29K | $45K |
| **Total Assets** | $8.19M | $4.09M | $8.80M | $28.05M | $42.59M | $36.80M | $15.31M | $19.82M | $26.00M | $19.66M |
| Accounts Payable | $617K | $4.60M | $3.54M | $2.56M | $2.12M | $514K | $890K | $2.72M | $1.56M | $2.50M |
| Other Current Liabilities | -- | -- | -- | -- | -- | -- | -- | $100K | $124K | $130K |
| **Total Current Liabilities** | $1.33M | $6.27M | $8.16M | $7.51M | $5.29M | $2.49M | $2.42M | $4.45M | $4.11M | $5.26M |
| Other Non-Current Liabilities | -- | -- | -- | -- | -- | -- | -- | $100K | $124K | $130K |
| **Total Non-Current Liabilities** | $11K | $0 | $37K | $106K | $30K | $1.06M | $1.19M | $100K | $124K | $130K |
| **Total Liabilities** | $1.34M | $6.27M | $8.20M | $7.62M | $5.32M | $3.54M | $3.61M | $4.55M | $4.24M | $5.39M |
| **Total Debt (incl. Leases)** | $20K | $5.0K | $37K | $106K | $30K | $1.06M | $1.19M | -- | -- | -- |
| Common Stock | $5.0K | $9.0K | $1.0K | $1.0K | $10K | $6.0K | $1.0K | $12K | $12K | $4.0K |
| Retained Earnings | -$454.4M | -$439.5M | -$428.3M | -$405.7M | -$385.0M | -$366.1M | -$357.6M | -$349.8M | -$342.5M | -$335.0M |
| Accumulated Other Comp. Income | -$39K | -$891K | -$908K | -$1.32M | -$748K | -$746K | -$819K | -$760K | -$794K | -$743K |
| **Total Stockholders' Equity** | $6.84M | -$2.17M | $607K | $15.94M | $37.69M | $33.26M | $11.70M | $15.27M | $21.77M | $14.27M |
| Total Equity | $6.84M | -$2.17M | $607K | $15.94M | $37.69M | $33.26M | $11.70M | $15.27M | $21.77M | $14.27M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $3.45M | $3.79M | $3.34M | $3.50M | $3.84M | $4.28M | $3.45M | $3.14M |
| **Cash & Short-Term Investments** | $3.45M | $3.79M | $3.34M | $3.50M | $3.84M | $4.28M | $3.45M | $3.14M |
| Accounts Receivable, Net | $974K | $1.07M | $1.19M | $1.26M | $725K | -- | -- | -- |
| Inventory | $991K | $972K | $947K | $1.38M | $1.37M | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | $460K | $58K | $194K | $317K |
| **Total Current Assets** | $5.58M | $5.97M | $5.62M | $6.26M | $6.44M | $4.38M | $3.71M | $3.67M |
| Property, Plant & Equipment, Net | $134K | $136K | $138K | $137K | $129K | $1.0K | $1.0K | $3.0K |
| Goodwill | $1.57M | $1.57M | $1.57M | $1.57M | $1.57M | -- | -- | -- |
| **Total Non-Current Assets** | $1.90M | $1.89M | $1.94M | $1.93M | $1.71M | $18K | $20K | $420K |
| **Total Assets** | $7.48M | $7.85M | $7.56M | $8.19M | $8.16M | $4.40M | $3.73M | $4.09M |
| Accounts Payable | $181K | $189K | $256K | $617K | $468K | $221K | $114K | $4.60M |
| **Total Current Liabilities** | $815K | $692K | $796K | $1.33M | $1.00M | $760K | $663K | $6.27M |
| **Total Non-Current Liabilities** | $2.0K | $2.0K | $8.0K | $11K | $60K | $10K | $9.0K | $0 |
| **Total Liabilities** | $817K | $694K | $804K | $1.34M | $1.06M | $770K | $672K | $6.27M |
| **Total Debt (incl. Leases)** | -- | -- | -- | $20K | $5.0K | $10K | $9.0K | $5.0K |
| Common Stock | $7.0K | $7.0K | $5.0K | $5.0K | $3.0K | $2.0K | $204K | $9.0K |
| Retained Earnings | -$455.5M | -$455.0M | -$454.6M | -$454.4M | -$444.3M | -$441.8M | -$440.5M | -$439.5M |
| Accumulated Other Comp. Income | -$30K | -- | -$30K | -$39K | -- | -- | -- | -$891K |
| **Total Stockholders' Equity** | $6.66M | $7.16M | $6.76M | $6.84M | $7.10M | $3.63M | $3.06M | -$2.17M |
| Total Equity | $6.66M | $7.16M | $6.76M | $6.84M | $7.10M | $3.63M | $3.06M | -$2.17M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$3.00M | -$11.21M | -$22.55M | -$21.20M | -$18.89M | -$8.45M | -$7.83M | -$7.29M | -$7.47M | -$11.79M |
| Depreciation & Amortization | $5.0K | $6.0K | $31K | $32K | $43K | $20K | $20K | $29K | $32.00M | $100K |
| Stock-Based Compensation | $2.33M | $592K | $1.47M | $1.51M | $1.16M | $430K | $466K | $331K | $266K | $782K |
| Change in Receivables | -$1.26M | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Change in Inventory | -$1.38M | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| **Operating Cash Flow** | -$4.77M | -$7.99M | -$16.11M | -$20.83M | -$18.54M | -$7.93M | -$9.45M | -$6.70M | -$7.48M | -$10.08M |
| Capital Expenditure | -- | -- | -$6.0K | -$7.0K | -$27K | -$96K | -$10K | -$39K | -$13K | -$3.0K |
| **Free Cash Flow** | -- | -- | -$16.12M | -$20.83M | -$18.57M | -$8.03M | -$9.46M | -$6.74M | -$7.49M | -$10.08M |
| **Investing Cash Flow** | -- | -- | -$6.0K | -$7.0K | -$27K | -$96K | $28K | -$39K | -$13K | $9.0K |
| Common Stock Issued | $6.42M | $6.21M | $1.05M | -- | $4.00M | $29.70M | $4.05M | $630K | $14.75M | $6.79M |
| **Financing Cash Flow** | $5.26M | $7.82M | $848K | $3.00M | $21.74M | $29.50M | $3.85M | $429K | $14.75M | $6.59M |
| **Net Change in Cash** | $368K | -$241K | -$14.97M | -$18.21M | $3.15M | $21.52M | -$5.62M | -$6.41M | $7.39M | -$3.92M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$449K | -$405K | -$197K | -$611K | -$988K | -$1.32M | -$81K | -$3.05M |
| Depreciation & Amortization | $0 | $0 | $1.0K | -- | -- | -- | -- | $1.0K |
| Stock-Based Compensation | $0 | $0 | $1.0K | $655K | $6.0K | $7.0K | $1.67M | $93K |
| Change in Receivables | $100K | $114K | $69K | -- | -- | -- | -- | -- |
| Change in Inventory | -$19K | -$25K | $437K | -- | -- | -- | -- | -- |
| **Operating Cash Flow** | -$287K | -$352K | -$278K | -$33K | -$434K | -$1.06M | -$3.25M | -$1.36M |
| Capital Expenditure | $0 | $0 | -$1.0K | -- | -- | -- | -- | -- |
| **Free Cash Flow** | -$287K | -$352K | -$279K | -- | -- | -- | -- | -- |
| **Investing Cash Flow** | $0 | $0 | -$1.0K | -- | -- | -- | -- | -- |
| Common Stock Issued | $0 | $794K | $125K | $861K | -$3.0K | $1.67M | $3.89M | -- |
| **Financing Cash Flow** | -$20K | $773K | $105K | -$259K | -$3.0K | $1.88M | $3.65M | $1.61M |
| **Net Change in Cash** | -$336K | $451K | -$166K | -$333K | -$437K | $825K | $313K | $155K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -27916.3% | -6060.2% | -- | -- | -- | -- | -6365.3% | -- | -1678.5% |
| **Net Profit Margin** | -- | -26074.4% | -5370.2% | -- | -- | -- | -- | -4858.7% | -- | -1398.7% |
| Return on Equity (ROE) | -43.8% | -- | -3715.8% | -133.0% | -50.1% | -25.4% | -66.9% | -47.7% | -34.3% | -82.6% |
| Return on Assets (ROA) | -36.6% | -273.9% | -256.2% | -75.6% | -44.3% | -22.9% | -51.1% | -36.8% | -28.7% | -60.0% |
| Current Ratio | 4.70x | 0.59x | 0.91x | 3.25x | 7.73x | 14.27x | 5.79x | 4.45x | 6.32x | 3.73x |
| Quick Ratio | 3.66x | 0.50x | 0.41x | 3.05x | 7.75x | 15.58x | 9.52x | 7.68x | 11.36x | 5.27x |
| Debt to Equity | 0.00x | -- | 0.06x | 0.01x | 0.00x | 0.03x | 0.10x | -- | -- | -- |
| **Revenue Growth (YoY)** | -100.0% | -89.8% | -- | -- | -- | -- | -- | -- | -100.0% | -56.6% |
| 5Y Revenue / Share Growth | -- | -- | -86.8% | -- | -100.0% | -100.0% | -- | -82.6% | -100.0% | +153.8% |
| 10Y Revenue / Share Growth | -100.0% | -100.0% | -97.7% | -100.0% | -100.0% | -100.0% | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -- | -- | -- | -- | -- | -- | -- | -27916.3% |
| **Net Profit Margin** | -- | -- | -- | -- | -- | -- | -- | -26074.4% |
| Return on Equity (ROE) | -25.0% | -30.7% | -46.1% | -43.8% | -76.6% | -176.5% | -272.6% | -- |
| Return on Assets (ROA) | -22.2% | -28.0% | -41.2% | -36.6% | -66.7% | -145.6% | -223.5% | -273.9% |
| Current Ratio | 6.84x | 8.63x | 7.06x | 4.70x | 6.43x | 5.77x | 5.60x | 0.59x |
| Quick Ratio | 5.63x | 7.22x | 5.87x | 3.66x | 5.07x | 5.62x | 5.20x | 0.50x |
| Debt to Equity | -- | -- | -- | 0.00x | 0.00x | 0.00x | 0.00x | -- |
| **Revenue Growth (YoY)** | +460.5% | -- | -- | -- | +710.0% | -- | -- | -100.0% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
